Mount Olive Chronicle on MSN
New drug nearly doubles pancreatic cancer survival rates in 2026 breakthrough
A groundbreaking drug has nearly doubled survival rates for pancreatic cancer patients, offering new hope in the fight ...
Pancreatic cancer remains one of the deadliest forms of cancer worldwide, with most patients diagnosed only after the disease has already spread. Survival rates have improved little over decades, ...
Researchers demonstrate breakthroughs in cancer treatment quality through AI-enhanced data analytics
Cancer researchers at the University of Tennessee Health Science Center have published three new studies demonstrating how advanced artificial intelligence and population health analytics can identify ...
Drug that stops cancer cells hiding and a breakthrough pill for pancreatic cancer among highlights from Asco conference – but there were also notes of caution ...
Breakthrough Study Confirms HYD’s 30-Year Research on Deuterium Modulation in Cancer Gene Expression
The first study on deuterium-depleted water (DDW) concluded that a higher D/H ratio inside cells can trigger cell division. This was supported by lab experiments showing that lowering deuterium levels ...
Promising new research suggests a triple threat approach could help treat pancreatic cancer. Researchers in Spain have developed a new therapy protocol that could revolutionize the treatment of ...
Medical discoveries don’t happen overnight. Often, it takes decades of research and development in the lab to deliver treatments that cure cancer outright or give patients precious time with their ...
LOS ANGELES — City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation’s top ...
The 5th Anniversary V Foundation for Cancer Research Sonoma Epicurean announced over $3.5 million raised to accelerate lifesaving cancer research. Held March 26–29, the event united Sonoma County’s ...
Scientists in South Korea have made a breakthrough in colorectal cancer research, the second-most common cause of cancer casualties in the United States. The illness refers to an abnormal growth of ...
Scientists engaged in cancer drug development utilize a range of model systems, including various in vivo, in vitro, and emerging approaches. Antibodies play an important role in this research and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results